The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of familial disease status with inferior treatment outcome in patients with Waldenstrom’s macroglobulinemia.
Z. R. Hunter
No relevant relationships to disclose
C. Hanzis
No relevant relationships to disclose
L. Ioakimidis
No relevant relationships to disclose
C. Tripsas
No relevant relationships to disclose
R. J. Manning
No relevant relationships to disclose
C. J. Patterson
No relevant relationships to disclose
P. Sheehy
No relevant relationships to disclose
B. Turnbull
No relevant relationships to disclose
S. P. Treon
No relevant relationships to disclose